No abstract available
Keywords:
SGLT2 inhibitor; antidiabetic drug; population study; primary care; type 1 diabetes.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Austria
-
Diabetes Mellitus, Type 1* / complications
-
Diabetes Mellitus, Type 1* / drug therapy
-
Diabetic Ketoacidosis* / epidemiology
-
Diabetic Ketoacidosis* / prevention & control
-
Germany
-
Glucose
-
Glycated Hemoglobin
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Registries
-
Sodium
-
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
-
Symporters*
Substances
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors
-
Symporters
-
Sodium
-
Glucose